Recent research at Sheba Medical Center is uncovering the microbiome’s significant role in cancer treatment. Dr Ben Boursi, a physician in the Gastrointestinal Cancer Department, and his team are exploring how the bacteria, viruses, and fungi within our bodies influence cancer progression and treatment responses. Their study suggests that unique microbial signatures may predict how patients respond to therapies. In a recent clinical trial, metastatic melanoma patients who hadn’t responded to conventional treatments showed promising responses to fecal microbiome transplantation (FMT).